• About Us
    • What We Do
    • Our Story
    • Meet Our Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Careers
    • Australia
    • United States
  • Contact
  • About Us
    • What We Do
    • Our Story
    • Meet Our Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Careers
    • Australia
    • United States
  • Contact
Ellume announces global partnership with QIAGEN for COVID-19 diagnosis

Ellume announces global partnership with QIAGEN for COVID-19 diagnosis

Highlights Ellume builds on existing partnership with global diagnostics company QIAGEN, to bring a rapid, reliable COVID antibody test to market QIAreach™ Anti-SARS-CoV-2 Total serology test has been submitted for US FDA Emergency Use Authorization 900,000 tests pre-ordered Brisbane, Australia – 25 August 2020 Digital diagnostics firm Ellume Ltd (Ellume or “the Company”) has extended […]
Read More
World TB Day 2020

World TB Day 2020

#ItsTimeToEndTB: Diagnostics are critical in infectious disease control Written by Dr Sean Parsons, CEO Ellume. As the world rallies to curb the spread of COVID-19, this year’s World Tuberculosis Day serves as a stark reminder that the two major biological threats to humans are pandemic viruses (like COVID-19) and tuberculosis (TB) – especially multi-drug resistant […]
Read More
Ellume appoints Joanne Moss to its Board as Non-executive Director

Ellume appoints Joanne Moss to its Board as Non-executive Director

Brisbane, Australia – 12 November 2019 Ellume Limited (Ellume) is pleased to announce the appointment of Ms Joanne Moss to its Board as an Independent Non-Executive Director and Chair of Audit and Risk, effective immediately. This appointment supports Ellume’s commitment to good governance and strengthens management resources in preparation for US commercialisation and potential upcoming […]
Read More
How Digital Diagnostics Are Changing Healthcare

How Digital Diagnostics Are Changing Healthcare

The Importance of Accurate Tests to Good Medicine – Despite advances in healthcare over recent decades, infectious diseases remain burdensome illnesses. Influenza kills more people in America than car accidents, tuberculosis kills over 5,000 people every day around the world, and antimicrobial resistance is a growing threat.
Read More
Ellume shines at AFR BOSS’ Most Innovative Companies Awards

Ellume shines at AFR BOSS’ Most Innovative Companies Awards

We’re excited to announce Ellume was recognised as one of Australia and New Zealand’s Most Innovative Companies in 2019, ranking #2 on the Health and Pharmaceutical list published by The Australian Financial Review and Boss Magazine. The prestigious annual list is based on a rigorous  assessment process managed by Australia’s leading innovation consultancy, Inventium, in […]
Read More
The 10 most innovative health companies

The 10 most innovative health companies

The AFR BOSS Most Innovative Companies list recognises the most innovative organisations in Australia and New Zealand, as judged by the expert panel assembled by The Australian Financial Review and Inventium.
Read More
From the emergency ward to pitching an IPO

From the emergency ward to pitching an IPO

Sean Parsons was a medical emergency doctor during the 2009 swine flu pandemic in Queensland when he decided to develop a home-test kit for the flu.
Read More
Flu-diagnostics startup Ellume raises $5 million as it gears up for IPO

Flu-diagnostics startup Ellume raises $5 million as it gears up for IPO

Brisbane Medtech startup Ellume has secured $5 million in funding for commercialising and developing its diagnostics products as it ramps up to listing on the ASX.
Read More
Ellume, the digital diagnostics company helping people beat the flu

Ellume, the digital diagnostics company helping people beat the flu

Dr Sean Parsons is the founder of Ellume, an emerging digital diagnostics company situated in Brisbane that provides smart, self-use diagnostics for the detection and management of pandemic influenza.
Read More
Meet the Aussie entrepreneur letting you diagnose the flu through your smartphone

Meet the Aussie entrepreneur letting you diagnose the flu through your smartphone

Imagine being able to accurately diagnose common illnesses such as the flu, submit that diagnosis to a medical professional, and receive advice and a prescription for treatment, all without ever having to leave your bed.
Read More
Page 4 of 512345
Recent Posts
  • QIAGEN receives U.S. FDA emergency use authorization for rapid portable SARS-CoV-2 antigen test
  • Push to allow at-home COVID tests in Australia
  • Why Aussie startup Ellume’s home-testing tech should help us in the COVID-19 recovery, but can’t
  • An Australian firm producing home COVID-19 tests for the US market has called on the federal government to reconsider its ban
  • Rapid COVID-19 Testing Device, Sunrise Interview with Ellume CEO Dr Sean Parsons
Archives
Categories
Business
Scroll
ellume logo white
Menu

Home
About Us
COVID-19 Response
Consumer Products
Professional Products
Global Public Health Solutions
Our Tech
News

Quick Links

Contact Us
Terms of Use
Privacy Policy
Whistleblower Policy

Some Ellume products are pending regulatory clearance. © Ellume Limited 2021
ABN 13 141 767 660